Xiaojun Han

Xiaojun Han, currently the Director of Medicinal Chemistry at Zentalis Pharmaceuticals, is well-known as the head chemist and lead inventor of Zentalis ADC platforms. With a background as an Associate Director at Zentalis Pharmaceuticals and a Principal Scientist at Bristol-Myers Squibb Co., Xiaojun has experience in various programs including fibrosis, cardiovascular, immunology, oncology, schizophrenia, and Alzheimer's disease. Educationally, Xiaojun holds a Post Doc from Harvard University and a Doctor of Philosophy - PhD from Iowa State University with a focus on Organic Chemistry.